These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12243114)

  • 21. Down syndrome screening marker levels in women with a previous aneuploidy pregnancy.
    Cuckle HS; Spencer K; Nicolaides KH
    Prenat Diagn; 2005 Jan; 25(1):47-50. PubMed ID: 15662693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Technic, indications and risks in genetic amniocentesis during early pregnancy].
    Husslein P; Wagenbichler P
    Wien Med Wochenschr; 1980 Jan; 130(2):93-5. PubMed ID: 6446206
    [No Abstract]   [Full Text] [Related]  

  • 23. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
    Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Which prenatal screening protocol?
    Ferguson-Smith MA
    Prenat Diagn; 2004 Oct; 24(10):761. PubMed ID: 15503274
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mongolism following omitted amniocentesis].
    Fortschr Med; 1984 Feb; 102(8):68. PubMed ID: 6235162
    [No Abstract]   [Full Text] [Related]  

  • 27. Preimplantation genetic diagnosis does not increase pregnancy rates in patients at risk for aneuploidy.
    Shahine LK; Cedars MI
    Fertil Steril; 2006 Jan; 85(1):51-6. PubMed ID: 16412730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytogenetic analysis of 6,142 amniocentesis cases: A 6-year single centre experience.
    Ekin A; Gezer C; Taner CE; Ozeren M; Avci ME; Uyar I; Ertas IE
    J Obstet Gynaecol; 2014 Oct; 34(7):571-5. PubMed ID: 24867317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individualized choice in prenatal diagnosis: the impact of karyotyping and standalone rapid aneuploidy detection on quality of life.
    Boormans EM; Birnie E; Oepkes D; Boekkooi PF; Bonsel GJ; van Lith JM;
    Prenat Diagn; 2010 Oct; 30(10):928-36. PubMed ID: 20730751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No beneficial effect of preimplantation genetic screening in women of advanced maternal age with a high risk for embryonic aneuploidy.
    Twisk M; Mastenbroek S; Hoek A; Heineman MJ; van der Veen F; Bossuyt PM; Repping S; Korevaar JC
    Hum Reprod; 2008 Dec; 23(12):2813-7. PubMed ID: 18567895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of the indications for genetic amniocentesis after the introduction of the prenatal screening program by the national health insurance in Poland.
    Ciach K; Swiatkowska-Freund M; Preis K
    Ginekol Pol; 2013 Jun; 84(6):418-21. PubMed ID: 24032258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Amniocentesis at 12 or 15 weeks?].
    Muller F; Tachdjian G
    Contracept Fertil Sex; 1999 Apr; 27(4):277-8. PubMed ID: 10349770
    [No Abstract]   [Full Text] [Related]  

  • 34. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S; Chandeying V
    J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening.
    Jou HJ; Kuo YS; Hsu JJ; Shyu MK; Hsieh TT; Hsieh FJ
    Prenat Diagn; 2005 Aug; 25(8):665-70. PubMed ID: 16049991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregnancy loss rates after midtrimester amniocentesis.
    Eddleman KA; Malone FD; Sullivan L; Dukes K; Berkowitz RL; Kharbutli Y; Porter TF; Luthy DA; Comstock CH; Saade GR; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME
    Obstet Gynecol; 2006 Nov; 108(5):1067-72. PubMed ID: 17077226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of maternal anxiety levels before and after amniocentesis.
    Ng CC; Lai FM; Yeo GS
    Singapore Med J; 2004 Aug; 45(8):370-4. PubMed ID: 15284930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers.
    Dugoff L; Cuckle HS; Hobbins JC; Malone FD; Belfort MA; Nyberg DA; Comstock CH; Saade GR; Eddleman KA; Dar P; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
    Am J Obstet Gynecol; 2008 Sep; 199(3):290.e1-6. PubMed ID: 18771987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normal obstetric ultrasound reduces the risk of Down syndrome in fetuses of older mothers.
    Anderson NG; Luehr B; Ng R
    Australas Radiol; 2006 Oct; 50(5):429-34. PubMed ID: 16981938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced first trimester screening (AFS): an improved test strategy for the individual risk assessment of fetal aneuploidies and malformations.
    Schmidt P; Rom J; Maul H; Vaske B; Hillemanns P; Scharf A
    Arch Gynecol Obstet; 2007 Aug; 276(2):159-66. PubMed ID: 17342500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.